Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Schenck

Showing results (11-20 of 139) with videos related to

Pageof 14
Sort By:
Acta Odontologica Scandinavica|August 15, 2001
Innate and acquired immunity, cytokines, and genetic factors in relation to the mucosal immune systemK Schenck, H Kiyono
Die Medizinische Welt|June 14, 1974
[Therapy of anorexia nervosa]K Schenck, G Deegener
Lakartidningen|November 24, 1993
[Healthy and beautiful teeth can be the cause of bad heart]F Gadler, K Schenck-Gustafsson
The Journal of Pharmacology and Experimental Therapeutics|August 24, 1999
5-Hydroxytryptamine(1F) receptors do not participate in vasoconstriction: lack of vasoconstriction to LY344864, a selective serotonin(1F) receptor agonist in rabbit saphenous veinM L Cohen, K Schenck
British Journal of Pharmacology|October 4, 2000
Contractile responses to sumatriptan and ergotamine in the rabbit saphenous vein: effect of selective 5-HT(1F) receptor agonists and PGF(2alpha)M L Cohen, K Schenck
Lakartidningen|April 23, 1980
[Quinidine-digoxin interaction-clinical therapy and pharmacokinetics]R Dahlgvist, K Schenck-Gustafsson
European Heart Journal|August 24, 1999
The careers of female cardiologistsL Rydén, K Schenck-Gustafsson
Diabetologia|September 5, 2012
Type 2 diabetes and cardiovascular disease in womenA Norhammar, K Schenck-Gustafsson
Lakartidningen|February 10, 1999
[New studies on the cardiac effect of estrogens in women. Hormone replacement as secondary prevention is not to be recommended]K Schenck-Gustafsson, N Rehnqvist
Medical Times|March 19, 2010
Case reports covering the usage of diethylstilbestrol for the treatment and prevention of accidents of pregnancyR S MILLEN, K SCHENCK
Pageof 14

Showing results (11-20 of 139) with videos related to

Sort By:
Pageof 14
Acta Odontologica Scandinavica|August 15, 2001
Innate and acquired immunity, cytokines, and genetic factors in relation to the mucosal immune systemK Schenck, H Kiyono
Die Medizinische Welt|June 14, 1974
[Therapy of anorexia nervosa]K Schenck, G Deegener
Lakartidningen|November 24, 1993
[Healthy and beautiful teeth can be the cause of bad heart]F Gadler, K Schenck-Gustafsson
The Journal of Pharmacology and Experimental Therapeutics|August 24, 1999
5-Hydroxytryptamine(1F) receptors do not participate in vasoconstriction: lack of vasoconstriction to LY344864, a selective serotonin(1F) receptor agonist in rabbit saphenous veinM L Cohen, K Schenck
British Journal of Pharmacology|October 4, 2000
Contractile responses to sumatriptan and ergotamine in the rabbit saphenous vein: effect of selective 5-HT(1F) receptor agonists and PGF(2alpha)M L Cohen, K Schenck
Lakartidningen|April 23, 1980
[Quinidine-digoxin interaction-clinical therapy and pharmacokinetics]R Dahlgvist, K Schenck-Gustafsson
European Heart Journal|August 24, 1999
The careers of female cardiologistsL Rydén, K Schenck-Gustafsson
Diabetologia|September 5, 2012
Type 2 diabetes and cardiovascular disease in womenA Norhammar, K Schenck-Gustafsson
Lakartidningen|February 10, 1999
[New studies on the cardiac effect of estrogens in women. Hormone replacement as secondary prevention is not to be recommended]K Schenck-Gustafsson, N Rehnqvist
Medical Times|March 19, 2010
Case reports covering the usage of diethylstilbestrol for the treatment and prevention of accidents of pregnancyR S MILLEN, K SCHENCK
Pageof 14